Cargando…
c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target
BACKGROUND: c-Met is widely known as a poor prognostic factor in various human malignancies. Previous studies have suggested the involvement of c-Met and/or its ligand, hepatocyte growth factor (HGF), in esophageal squamous cell carcinoma (ESCC), but the correlation between c-Met status and clinical...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453225/ https://www.ncbi.nlm.nih.gov/pubmed/26036285 http://dx.doi.org/10.1186/s12885-015-1450-3 |